Pharmacokinetics and pharmacodynamics of remifentanil II. Model application

Anesthesiology

Volumn 86, Issue 1, 1997, Pages 21-33

  Minto, Charles F ^a,b   Schnider, Thomas W ^a,b   Shafer, Steven L ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Analgesic, opioids: G187084B; remifentanil; Computer simulations; Pharmacodynamics: remifentanil; Pharmacokinetics: remifentanil; population

Indexed keywords

REMIFENTANIL; PIPERIDINE DERIVATIVE;

ADULT; AGED; AGING; ANESTHESIA MECHANISM; ARTICLE; BOLUS INJECTION; COMPUTER SIMULATION; DOSE CALCULATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG EFFECT; ELECTROENCEPHALOGRAM; HUMAN; HUMAN EXPERIMENT; LEAN BODY WEIGHT; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; BIOLOGICAL MODEL; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED;

ADULT; AGED; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PIPERIDINES;

EID: 0030641551     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJM, Gambus PL, Billard V, Hoke JF, Moore KHP, Hermann DJ, Muir KT, Mandema JW, Shafer SL: Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development, ANESTHESIOLOGY 1997; 86:10-23
2. Bailey JM, Shafer SL: A simple analytical solution to the three-compartment pharmacokinetic model suitable for computer-controlled Infusion pumps. IEEE Trans Biomed Eng 1991; 38:522-5
3. Shafer SL, Gregg KM: Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump, J Pharmacokinet Biopharm 1992; 20:147-69
4. Henthorn TK, Krejcie TC, Shanks CA, Avram MJ: Time-dependent distribution volume and kinetics of the pharmacodynamic effector site (letter). J Pharm Sci 1992; 81:1136-8
5. Shafer SL, Varvel JR: Pharmacokinetics, pharmacodynamics, and rational opioid selection. ANESTHESIOLOGY 1991; 74:53-63
6. Hughes MA, Glass PS, Jacobs JR: Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. ANESTHESIOLOGY 1992; 76:334-41
7. Kapila A, Glass PSA, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL: Measured context-sensitive half-times of remifentanil and alfentanil. ANESTHESIOLOGY 1995; 83:968-75
8. Schnider TW, Shafer SL: Evolving clinically useful predictors of recovery from intravenous anesthetics (editorial). ANESTHESIOLOGY 1995; 83:902-5
9. Maitre PO, Vozeh S, Heykants J, Thomson DA, Stanski DR: Population pharmacokinetics of alfentanil: The average dose-plasma concentration relationship and interindividual variability in patients. ANESTHESIOLOGY 1987; 66:3-12
10. Scott JC, Stanski DR: Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987; 240:159-66
11. Gepts E, Shafer SL, Camu F, Stanski DR, Woestenborghs R, van Peer A, Heykants JJ: Linearity of pharmacokinetics and model estimation of sufentanil. ANESTHESIOLOGY 1995; 83:1194-1204
12. Cambareri JJ, Afifi MS, Glass PS, Esposito BF, Camporesi EM: A-3665, a new short-acting opioid: A comparison with alfentanil. Anesth Analg 1993; 76:812-16
13. Lemmens HJM, Dyck JB, Shafer SL, Stanski SL: Pharmacokinetic-pharmacodynamic modeling in drug development: Application to the investigationl opioid trefentanil. Clin Pharmacol Ther 1994; 56:261-71
14. Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL: Remifentanil vs alfentanil: Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. ANESTHESIOLOGY 1996; 84:821-33